@jbluhm86 said:

Those articles are about the COVID-19 vaccine. The original was about Regeneron's ebola treatment, which has been in development since late 2014. 

The COVID vaccine is a unique case, but most vaccines take 6-10 years to reach the market from initial development.

true, but fast track also included Regeneron as a covid treatment.

https://bgr.com/2020/07/08/coronavirus-treatment-regeneron-monoclonal-antibodies-cure-regn-cov2-5852677/

US government invested $450M in breakthrough coronavirus drug

• A potential coronavirus treatment received a massive capital infusion from the US government.
• Regeneron’s REGN-COV2 monoclonal antibody drug might both treat COVID-19 patients and prevent infection in healthy individuals.
• The company is running separate treatment and prevention campaigns for the drug, and the clinical trials have reached advanced phases.
• The US government’s $450 million investment would cover tens to hundreds of thousands of doses, which could be ready for emergency use this fall.

"The first new drugs to treat the illness are here, but both remdesivir and dexamethasone are imperfect. The former works only in mild cases, can’t reduce mortality, and is in tight supply. The latter is cheap, is effective in severe cases, but doesn’t eliminate the risk of death altogether. There are several other therapies in clinical trials. As more time passes, researchers are getting closer to finding out if their new drugs can kill the virus, and whether they’re safe for patients. It’s not just vaccine candidates that have advanced towards the late stages of testing, but also a different type of medicine, which could save lives and prevent infections even before the vaccines are widely used. And the US government just invested $450 million towards manufacturing doses of one such drug, even before studies are completed. "

"The press announcement says the company is still evaluating the effective dosage for REGN-COV2. The agreement will cover anywhere between 70,000 and 300,000 treatment doses and 420,000 to 1.3 million preventive doses. These doses will be available this fall if all goes well with the separate clinical trials.

As with vaccines, there’s no guarantee REGN-COV2 will work, but the good news is Regeneron isn’t the only company developing monoclonal antibodies. Hopefully, at least one of these drugs will work. The figures above might not be enough to satisfy demand come fall when a second wave is expected."

The COVID vaccine is a unique case, but most vaccines take 6-10 years to reach the market from initial development.

@jbluhm86 said:

How exactly is this an achievement of the Trump administration? If anything, it's an accomplishment of the pharmaceutical company that created it.

fair question.

McEnany praises Trump for fast-tracking 'landmark' COVID ...

https://www.foxnews.com/transcript/mcenany-praises...

Oct 10, 2020 · The president also fast-track several COVID-19 relief programs, including direct stimulus payments to you, the American people and American businesses.

Trump calls on FDA to fast-track coronavirus vaccine ...

https://www.rawstory.com/2020/09/trump-calls-on...

Sep 23, 2020 · President Donald Trump on Wednesday publicly called on the Food and Drug Administration to fast-track approvals of coronavirus vaccines after a fourth American drug company’s COVID-19 vaccine...